First Forecast
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
SeattlePI.com
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a..
First Forecast
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a..